MIT-Led Research Team Adds Compact Cas7-11 Enzyme to CRISPR Toolkit |
|
In 2021, researchers at the Massachusetts Institute of Technology's McGovern Institute for Brain Research discovered and characterized Cas7-11, the first CRISPR enzyme that makes precise, guided cuts to RNA strands without harming cells in the process. Now, with collaborators at the University of Tokyo, the same team reveals that Cas7-11 can be shrunk to a more compact version, making it an even more viable option for editing the RNA inside living cells.
|
|
|
|
|
Experts Enhance Editing Rates of CRISPR-Cas12a |
|
Scientists from the University of Massachusetts Chan Medical School reported the increased gene editing rate of Cas12a nucleases to almost 100%. Their findings, published in GEN Biotechnology journal, could improve the use of Cas12a to uncover functions of new genes and design new CRISPR-based treatments.
|
|
|
|
|
Research and Tools |
 |
|
Public Acceptance and Engagement |
 |
|
|
|
|
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10. |
|
|
|